Transfusion · 5 Nov 2026
Quality without a mandate: An exploratory national survey of perioperative autologous transfusion accreditation barriers
Gagan Mathurh-index 5, Nada Naiyer, Patricia Travassos, Jennifer O'Brien, Tonya Nuelle, Allan Klompas, Muharrem Yunce, David Moolten
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Abstract Background Perioperative autologous transfusion, encompassing intraoperative cell salvage (ICS), acute normovolemic hemodilution (ANH), and autologous component production, is integral to patient blood management. Association for the Advancement of Blood and Biotherapies (AABB) has published comprehensive quality standards, yet perioperative accreditation remains profoundly underutilized; fewer than 10 U.S. institutions are currently accredited. No prior study has characterized these barriers. Methods The AABB Perioperative Accreditation Committee administered a six‐item electronic survey to AABB members in August–September 2023, addressing services provided, program oversight, quality control (QC), governance, and accreditation barriers. Fifty‐seven complete responses were analyzed using descriptive statistics. This study met criteria for Non‐Human Subjects Research self‐determination. Results Seventy percent of respondents (40/57) reported providing perioperative services. Only 60% expressed a positive level of comfort with perioperative program oversight and patient safety; 28% were neutral and 12% were uncomfortable. More than one in four (28%) confirmed the absence of formal QC or did not know whether any was performed. No single discipline dominated governance, and 25% reported fragmented, unclear, or absent oversight. The most frequently cited barrier was that accreditation is not required, endorsed by 53%. Conclusions Perioperative autologous transfusion programs in the United States often operate without the quality oversight applied to every other blood component service. The dominant barrier is not cost or complexity but the absence of external accountability. Existing oversight through The Joint Commission, the College of American Pathologists (CAP), the Centers for Medicare & Medicaid Services (CMS), and AABB's Blood Bank and Transfusion Service (BBTS) accreditation does not extend to perioperative operations in any program‐specific sense. Practical frameworks exist; adoption requires action from professional societies, hospital leadership, and regulatory bodies.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Gagan Mathur has the highest h-index among the authors (5).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (20)
What it cites, from open citation data, with Crossref's record of each.